ArticleClinical case reports2026
Dieulafoy's Lesion of the Major Duodenal Papilla Presenting as Obscure Upper Gastrointestinal Bleeding: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dieulafoy's lesion is an uncommon vascular anomaly that can cause life-threatening gastrointestinal bleeding. While the stomach is the most frequently affected site, involvement of the major duodenal papilla is exceedingly rare and may escape detection with conventional forward-viewing endoscopy. We report a rare case of papillary Dieulafoy's lesion presenting as obscure upper gastrointestinal bleeding in a patient receiving rivaroxaban. A 69-year-old woman with deep vein thrombosis receiving rivaroxaban, hypertension, and hypothyroidism presented with recurrent melena and severe anemia (hemoglobin 5.8-7.1 g/dL). Despite extensive evaluation, including capsule endoscopy, colonoscopy, and two forward-viewing esophagogastroduodenoscopies, no bleeding source was identified. Persistent anemia and fresh blood in the second portion of the duodenum raised suspicion of a periampullary bleeding source. Side-viewing duodenoscopy subsequently identified a 1 × 1 mm erythematous lesion with active bleeding at the major duodenal papilla, consistent with a Dieulafoy's lesion. Combination endoscopic therapy with epinephrine injection, bipolar thermal coagulation, and hemoclip placement achieved complete hemostasis. Rivaroxaban was temporarily discontinued, and no recurrent bleeding or post-procedural pancreatitis occurred during 6 months of follow-up. This case highlights the diagnostic challenge of papillary Dieulafoy's lesions when conventional forward-viewing endoscopy is non-diagnostic. Early side-viewing duodenoscopy is essential when a periampullary bleeding source is suspected, and combination endoscopic therapy can provide durable hemostasis, even in anticoagulated patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.